First, our study groups were notably different: ours was clinical; theirs, epidemiological. As we discussed, studies with clinical study groups are limited by factors associated with selection bias (e.g., subjects are seeking treatment and are willing to participate in clinical research), and these subjects typically have higher levels of distress and comorbidity than do community samples. Conversely, epidemiologic studies are usually limited by the use of data based on nonclinician assessments and may tend to inflate rates of clinically significant psychiatric disorders since distress or impairment is typically much lower than in clinical settings.